# Dexmedetomidine on Microcirculation in Septic Shock

> **NCT02270281** · PHASE4 · COMPLETED · sponsor: **Southeast University, China** · enrollment: 44 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Dexmedetomidine 0.7 Mcg/kg/h

## Key facts

- **NCT ID:** NCT02270281
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-12
- **Final completion:** 2017-05
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2018-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02270281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02270281, "Dexmedetomidine on Microcirculation in Septic Shock". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02270281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*